These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
Last week shows that oil prices are not the indicator for Middle East tensions they once were, and worries about global demand and growing U.S. production has changed that...Market Insiderread more
Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
The firing of the tear gas was the latest confrontation between police and protesters who have taken to the streets for over a month to fight a proposed extradition bill and...China Politicsread more
Amazon's new policy for account suspensions doesn't go far enough to protect sellers from potentially unfair and wrongful suspensions, merchants say.Technologyread more
There is no end in sight to the Boeing 737 Max grounding after two fatal crashes, prompting airlines to rethink their growth plans.Airlinesread more
After a year of flooding, Midwest farmers face a stifling heat wave that's spreading across the U.S.Weather & Natural Disastersread more
Gluskin Sheff's David Rosenberg is painting a painful picture for stocks as earnings season goes into full gear.Futures Nowread more
Rossello is facing public furor over an obscenity-laced online chat that showed the governor and his close advisers insulting women and mocking constituents, including victims...Politicsread more
Federal criminal investigators have opened a new front in a probe of diagnostic testing company Alere, according to a new report that comes as the firm continues trying to sell itself to in a multibillion-dollar deal.
The Wall Street Journal reported Wednesday afternoon that Alere was hit was a subpoena seeking patient-billing records in June by the criminal-fraud section of the U.S. Justice Department.
The subpoena sought information about Alere's alleged "efforts to collect copayments from patients, as well as forms submitted on their behalf to government programs such as Medicare," according to the Journal, whose story cited sources familiar with the probe.
Alere shares plummeted by more than 28 percent to close at $31.60 on the heels of the news. In after-hours trading, the stock recovered some lost ground.
The newspaper, which noted that federal law prohibits health-care companies from covering medical payments for people insured by government programs such as Medicare, also said that prosecutors are looking into whether Alere gave doctors any money or "delivered items of value" to physicians.
In March, Alere revealed that the Justice Department served the company with a subpoena seeking information about sales practices overseas. That probe relates to the Foreign Corrupt Practices Act.
Both Alere and Abbott Labs declined to comment when contacted by CNBC. The Justice Department had no immediate comment.
Abbott's proposed $5.8 billion purchase of Alere, which was first revealed in February, has yet to close.
During a conference call last week, Abbott CEO Miles White said, "I have no particular predictions to make," referring to the deal, according to the the Chicago Tribune. The paper noted that Abbott had earlier tried to cancel the deal following Alere's disclosure of the subpoena in March.